Logo for Selecta Biosciences Inc

Selecta Biosciences Investor Relations Material

Latest events

Logo for Selecta Biosciences Inc

M&A Announcement

Selecta Biosciences
Logo for Selecta Biosciences

M&A Announcement

13 Nov, 2023
Logo for Selecta Biosciences

Q2 2023

17 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from over 8,000 public companies
Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company engaged in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The Company uses its proprietary Emulate(TM) technology to develop novel therapeutics that target receptors with high specificity for desired cellular targets as well as generate broad-spectrum immune suppression. Selecta Biosciences' wholly owned subsidiary is Emulate Biosciences Corporation, which was founded in 2003 to develop drug discovery technologies based on systems biology principles. Selecta Biosciences, Inc. was incorporated in 2007 and is headquartered in Watertown, Massachusetts.